Max Robotics — Global Service Robot Directory + US Certification

About

Markus Graefen is a prominent urological surgeon and researcher whose work sits at the intersection of oncologic surgery, minimally invasive techniques, and health outcomes research. His scholarship has made significant contributions to understanding the clinical and economic implications of robot-assisted surgery across major urological cancers, including bladder, kidney, and upper tract urothelial malignancies. Graefen's most impactful recent publications leverage large-scale national datasets — particularly the National Inpatient Sample — to rigorously compare robot-assisted and open surgical approaches across metrics such as in-hospital complications, adverse outcomes, and total hospital costs. His analyses of radical nephroureterectomy, radical cystectomy, and partial nephrectomy have helped clarify how robotic platforms perform relative to open surgery both historically and in contemporary practice, providing evidence that informs surgical decision-making at an institutional and policy level. With his most-cited 2025 paper on single-port robotic surgery already accumulating 22 citations within the year, Graefen is clearly shaping emerging conversations around next-generation robotic platforms in urology. His attention to vulnerable populations — such as octogenarians undergoing radical cystectomy — further reflects a nuanced, patient-centered research perspective. Graefen's body of work serves as an essential resource for surgeons, health economists, and trainees navigating the evolving landscape of urological cancer care.